Cristin Rothfuss
Vermogen: 2 M $ op 31-08-2026
Vermogen: 2 M $ op 31-08-2026
Cristin L.
Rothfuss is Executive Vice President & General Counsel at Sarepta Therapeutics, Inc. since 2026.
Formerly worked as Senior Associate Director at the Office of Technology Development.
Educated at Yale University (undergraduate) and Connecticut School of Law University Of (graduate).
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 04-09-2026 | 115.519 ( 0,11% ) | 2 M $ | 31-08-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| SAREPTA THERAPEUTICS, INC. | Algemeen Adviseur | 01-02-2021 |
| Bedrijven | Functie | Einde |
|---|---|---|
Office of Technology Development
Office of Technology Development Investment ManagersFinance Office of Technology Development invests in companies located in the United States. The firm focuses on health and technology sectors. It participates in early-stage transactions. | Corporate Officer/Principal | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 4 |
|---|---|
Sarepta Therapeutics, Inc.
Sarepta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures micro-dystrophin gene therapy | Health Technology |
Yale University
Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Office of Technology Development
Office of Technology Development Investment ManagersFinance Office of Technology Development invests in companies located in the United States. The firm focuses on health and technology sectors. It participates in early-stage transactions. | Finance |
Connecticut School of Law University Of
Connecticut School of Law University Of Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kies jouw editie
Alle financiële informatie op nationaal niveau